The University of Pennsylvania School of Veterinary Medicine (Penn Vet) recently opened its new, state-of-the-art minimally invasive surgical suite at the Matthew J. Ryan Veterinary Hospital. The Buerger Family Foundation Surgery Suite is the first of its kind in any veterinary teaching hospital and is one of the only operating rooms in veterinary medicine that offers a comprehensive array of minimally invasive surgical procedures for companion animals.
School of Veterinary Medicine
On Tuesday, December 6 the University of Pennsylvania School of Veterinary Medicine (Penn Vet) will host a free, open-to-the-public lecture called “Caring for Older Pets: Healthcare advice on geriatric and end-of-life issues,” at Penn Medicine in Radnor, PA. Beginning at 6:30 PM, Dr. Meryl Littman, associate professor of medicine at Penn Vet, will talk about the special considerations when caring for older pets and how to handle those difficult decisions end-of-life issues bring.
Sunil Singhal of the Perelman School of Medicine and David Holt of the School of Veterinary Medicine discuss new technology used for cancer research.
Philadelphia, PA – On Saturday, November 5 the University of Pennsylvania School of Veterinary Medicine (Penn Vet) will host a free, open-to-the-public lecture called “First Aid Care for Your Pet,” at Penn Vet in Philadelphia, PA. Beginning at 10:00 AM, Dr. Deborah Mandell, staff veterinarian of Ryan Hospital’s Emergency Service, will teach how to determine if a pet is in an emergency situation, and if so, what first-aid can be performed at home.
Who: Penn Vet, pet owners, interested members of the public.
PHILADELPHIA — Ralph Brinster of the University of Pennsylvania School of Veterinary Medicine has received the National Medal of Science.
PHILADELPHIA — An experimental vaccine developed by researchers at the University of Pennsylvania’s schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin’s lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types.